UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000024502 |
|---|---|
| Receipt number | R000028197 |
| Scientific Title | Effect of Empagliflozin on Endothelial Function in Cardiovascular High Risk Diabetes Mellitus: Multi-Center Placebo-Controlled Double-Blind Randomized Trial |
| Date of disclosure of the study information | 2016/10/21 |
| Last modified on | 2022/12/26 16:21:29 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/10/20 14:35:42 | ||
| 2 | Update | 2017/02/01 14:39:19 | Recruitment status |
|
| 3 | Update | 2017/02/01 14:41:15 | Organization Organization |
|
| 4 | Update | 2017/10/20 10:37:08 | Recruitment status |
|
| 5 | Update | 2018/06/08 13:29:27 | Institutions |
|
| 6 | Update | 2019/03/13 10:20:13 | UMIN ID1 |
|
| 7 | Update | 2019/03/13 13:27:16 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Zip code Last name of contact person Last name of contact person Division name Zip code Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Email1 Organization Organization Address Address Tel |
|
| 8 | Update | 2019/10/28 12:05:58 | Publication of results Number of participants that the trial has enrolled |
|
| 9 | Update | 2019/10/28 14:22:36 | Recruitment status Date of IRB Last follow-up date |
|
| 10 | Update | 2022/12/26 16:21:29 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
